Chang X et al.Orexin-A stimulates 3ß-hydroxysteroid dehydrogenase expression and cortisol production in H295R human adrenocortical cells through the AKT pathway.Int J Mol Med 34:1523-8 (2014).
Nakajima H et al.Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer.Breast Cancer 21:66-74 (2014).
Xu L et al.MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway.Mol Biol Cell 24:42-55 (2013).
Meyer S et al.A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts.PLoS One 7:e38222 (2012).
Cima I et al.Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer.Proc Natl Acad Sci U S A 108:3342-7 (2011).
Dupont J et al.FSH-stimulated PTEN activity accounts for the lack of FSH mitogenic effect in prepubertal rat Sertoli cells.Mol Cell Endocrinol 315:271-6 (2010).
Hager M et al.Increased activated Akt expression in renal cell carcinomas and prognosis.J Cell Mol Med 13:2181-8 (2009).
Jousan FD et al.Short-Term culture of in vitro produced bovine preimplantation embryos with insulin-like growth factor-i prevents heat shock-induced apoptosis through activation of the Phosphatidylinositol 3-Kinase/Akt pathway.Mol Reprod Dev 75:681-8 (2008).
Shah T et al.Epidermal growth factor receptor expression and activation in neuroendocrine tumours.J Neuroendocrinol 18:355-60 (2006).
Volanti C et al.Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumour cells after photodynamic therapy.Oncogene 24:2981-91 (2005).